| Literature DB >> 34360675 |
Jessica Maiuolo1, Irene Bava1, Cristina Carresi1, Micaela Gliozzi1, Vincenzo Musolino1, Miriam Scicchitano1, Roberta Macri1, Francesca Oppedisano1, Federica Scarano1, Maria Caterina Zito1, Francesca Bosco1, Stefano Ruga1, Saverio Nucera1, Sara Ilari1, Ernesto Palma1, Carolina Muscoli1, Vincenzo Mollace1.
Abstract
In recent decades, interest in natural compounds has increased exponentially due to their numerous beneficial properties in the treatment of various acute and chronic diseases. A group of plant derivatives with great scientific interest is terpenic compounds. Among the plants richest in terpenes, the genus Ferula L. is one of the most representative, and ferutinin, the most common sesquiterpene, is extracted from the leaves, rhizome, and roots of this plant. As reported in the scientific literature, ferutinin possesses antioxidant and anti-inflammatory properties, as well as valuable estrogenic properties. Neurodegenerative and demyelinating diseases are devastating conditions for which a definite cure has not yet been established. The mechanisms involved in these diseases are still poorly understood, and oxidative stress is considered to be both a key modulator and a common denominator. In the proposed experimental system, co-cultured human neurons (SH-SY5Y) and human oligodendrocytes (MO3.13) were treated with the pro-inflammatory agent lipopolysaccharide at a concentration of 1 μg/mL for 24 h or pretreated with ferutinin (33 nM) for 24 h and subsequently exposed to lipopolysaccharide 1 μg/mL for 24 h. Further studies would, however, be needed to establish whether this natural compound can be used as a support strategy in pathologies characterized by progressive inflammation and oxidative stress phenomena.Entities:
Keywords: demyelinating pathologies; ferutinin; inflammation; neurons; oligodendrocytes; oxidative stress
Year: 2021 PMID: 34360675 DOI: 10.3390/ijms22157910
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923